Pharma & Biotech

Viking Therapeutics experienced significant selling pressure yesterday as investors reacted to Pfizer's unexpected acquisition of competitor Metsera. The biotech firm's...

Bayer's subsidiary AskBio has initiated a European Phase II clinical trial for its innovative gene therapy candidate, AB-1005, targeting Parkinson's...

Idorsia Ltd. shares are demonstrating notable strength in today's trading session, propelled by two significant strategic developments that are prompting...

Shares of Reviva Pharmaceuticals Holdings have been on a rollercoaster ride after the company disclosed the completion of a public...

The inclusion of Compass Therapeutics in the S&P Biotechnology Select Industry Index represents a significant validation for the clinical-stage biotech...

A previously under-the-radar biotechnology firm, Astria Therapeutics, is now commanding significant market attention following the release of encouraging early-stage clinical...

Iovance Biotherapeutics has made a significant corporate announcement, detailing the issuance of new stock options. This move directly impacts the...

Tandem Diabetes Care finds itself at a critical juncture, pulled in opposite directions by promising clinical developments and a serious...

After an extended period of decline, BioNTech stock is showing signs of a potential recovery. Investor sentiment received a dual...

After a period of significant volatility, shares of Coherus BioSciences are demonstrating renewed momentum. The biotech firm's dramatic strategic shift...